Indapta Therapeutics
Houston, TX
Indapta Therapeutics is a biotechnology company focused on developing and commercializing a proprietary, off-the-shelf, allogeneic FcRγ-deficient natural killer (G-NK) cell therapy to treat multiple types of cancer.
indapta.comCompany Details
Founded
- 2017
Employees
- Between 10 - 50 employees
Raised
- $127,800,176
Headquarters Location
- Houston, TX
Public
- No
Acquired
- No
CEO
- Mark Frohlich
Founders
- Guy DiPierroRonald Martell
Company Collections
These are collections Indapta Therapeutics is a part of. Click on the collection name to view similar companies.